Dermatology

The AJMC® Dermatology compendium is a comprehensive resource for clinical news and expert insights for diseases related to the skin, hair, and nails.

Latest News

FDA stamp of approval | Image Credit: Olivier Le Moal - stock.adobe.com
FDA Approves Tapinarof Cream 1% for Patients With Atopic Dermatitis

December 16th 2024

The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis.

Collaborating for Cancer Care Equity:  Community and Academic Insights
Collaborating for Cancer Care Equity: Community and Academic Insights

November 21st 2024

Book titled hidradenitis suppurativa | Image Credit: Vitalii Vodolazskyi - stock.adobe.com
Hidradenitis Suppurativa Disproportionately Affects Black, Female Patients

September 25th 2024

Semaglutide | Image Credit: Corona Borealis - stock.adobe.com
Semaglutide Improves Hidradenitis Suppurativa in Patients With Obesity

September 24th 2024

Diversity animation | Image Credit: annaspoka - stock.adobe.com
Dermatologist Dissects Rosacea Diagnosis Challenges Among Patients of Color

September 17th 2024

Topical Therapies for the Treatment of Atopic Dermatitis: Balancing Safety, Efficacy, and Access

Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.

Atopic Dermatitis Payer Perspectives
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo